Deep Track Capital reported a 6.46% stake in MoonLake Immunotherapeutics MLTX · 4,610,071 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 6.46%
Last report: First report
Shares held: 4,610,071 sh
Class: Class A ordinary share, par value $0.0001 per share
Stock: MoonLake Immunotherapeutics MLTX
Holder: Deep Track Capital
Event date: 25/11/05
Filed: 25/11/12

First 5%+ report · 6.46% stake

MoonLake Immunotherapeutics trades, last 26 weeks

What else happened in MoonLake Immunotherapeutics around then

Filed or reported within 30 days of the trade day · 25/10/06~25/12/05

Deep Track Capital's other 5% stake reports

Deep Track Capital
5% stakeJatt III Acquisition
5% stake
Jatt III Acquisition
JTTT
5.83% stake
450,000 sh
5.83% stake
Filed 09/02
Deep Track Capital
5% stakeNurix Therapeutics
5% stake
Nurix Therapeutics
NRIX
7.45% stake
7,736,455 sh
7.45% stake
Filed 08/14
Deep Track Capital
5% stakeX4 Pharmaceuticals
5% stake
X4 Pharmaceuticals
XFOR
8.33% stake
8,040,894 sh
8.33% stake
Filed 08/14
Deep Track Capital
5% stakeViridian Therapeutics, Inc.\DE
5% stake
Viridian Therapeutics, Inc.\DE
VRDN
3.25% stake
3,592,740 sh
3.25% stake
Filed 08/14
Deep Track Capital
5% stakePersonalis
5% stake
Personalis
PSNL
3.82% stake
4,000,000 sh
3.82% stake
Filed 08/14